Sanchit Mehta, ECFMG-Certified Internal Medicine Residency Applicant, shared on LinkedIn:
“Grateful to have attended the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2026 in Boston and presented our work
‘Democratizing Cellular Therapeutics: A Review of Emerging CAR-T Trials in India in the Context of High-Cost Western Models.’
Our narrative review compared India’s emerging CAR-T landscape with the more established US baseline, highlighting the potential of decentralized, point-of-care manufacturing to reduce treatment costs.
However, given the relative novelty of CAR-T therapy in India, formal cost-effectiveness analyses are needed to determine whether these cost advantages translate into meaningful economic value and broader patient access.
Beyond presenting, I valued the opportunity to attend sessions exploring how we can deliver high-quality, value-based oncology care.
Dr. Samyukta Mullangi’s session, ‘What Makes Oncology Practices Financially Sustainable in Value-Based Care?’, offered valuable insights into the intersection of clinical quality, financial sustainability, and evolving models of cancer care delivery.
It was a reminder that advancing oncology requires not only scientific discovery, but also thoughtful approaches to making high-value, patient-centered care accessible.
As an international medical graduate navigating the transition toward Internal Medicine residency training in the United States, being part of a scientific meeting like ASCO QC holds special significance.
At this stage of my journey, the opportunity to present research on this platform, learn from leaders in oncology, and engage with a community committed to advancing cancer care is both humbling and motivating.
Every contribution, however small, is part of a much larger collective effort to advance science and improve patient outcomes. I’m grateful to have played a small part in that effort.
I am truly grateful to my mentors, Dr. Karine Tawagi and Dr. Natalie Reizine at The University of Illinois Cancer Center, for their guidance, encouragement, and continued support.
Their mentorship has been invaluable in nurturing my passion for oncology, deepening my appreciation for research that can meaningfully impact patient care, and inspiring my aspirations in academic medicine.
Thankful for the opportunity, the people I’ve learned from, and the chance to keep moving forward, one step at a time.”
Title: Democratizing Cellular Therapeutics: A Review of Emerging CAR-T Trials in India in the Context of High-Cost U.S. Models
Authors: Sanchit Mehta, Ahsan Wahab, Natalie Marie Reizine, Ana Avila Rodriguez, Karine Tawagi
Other articles about CAR-T Therapy on OncoDaily.
